results for first-line pembrolizumab in advanced urothelial carcinoma
Published 7 years ago • 88 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
2:15
results of a first-line study of pembrolizumab in advanced urothelial cancer
-
1:45
results for pembrolizumab as a first-line therapy for advanced urothelial carcinoma
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
2:41
firstline pembrolizumab for metastatic urothelial cancer
-
6:02
ev-103: ev pembrolizumab as a promising first-line option for urothelial carcinoma
-
1:36
pembrolizumab in urothelial cancer
-
3:21
esmo 2020 highlights on pembrolizumab as 1st line therapy for auc: the keynote-361 study
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
1:14
targeted therapy and immunotherapy combination for bladder cancer treatment
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer
-
1:54
two-year follow-up results from keynote-045 study in urothelial carcinoma
-
1:06
immunotherapy impacts in bladder cancer
-
2:10
initial ev-103 results: enfortumab vedotin plus pembrolizumab for urothelial carcinoma
-
25:35
innovative treatments for bladder cancer
-
1:47
current and upcoming clinical trials in bladder cancer
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
0:51
impact of the keynote-045 study comparing pembrolizumab and chemotherapy in bladder cancer